Dose: 8mg is recommended for women and 11mg for men
Research suggests GIP activation improves insulin sensitivity in adipose tissue, may contribute to central nervous system appetite regulation beyond what GLP-1 provides, and appears to reduce some of the gastrointestinal side effects associated with GLP-1 agonism alone
Tirzepatide went through rigorous clinical trials and became one of the most successful GLP-1 fat loss treatments in pharmaceutical history
Evaluating the rates of pancreatitis and pancreatic cancer among GLP-1 receptor agonists: a systematic review and meta-analysis of randomised controlled trials
References Yecies, T., Bandari, J., Schneck, F
It's like sending out delivery trucks that are too big to navigate the narrow city streets